comparemela.com

Latest Breaking News On - Sommer schmidt - Page 1 : comparemela.com

Restructuring proposal adopted by creditors

Orphazyme A/S in restructuring Company. | May 30, 2022

John sommer schmidtAnders vadsholtDrug administrationCompany registration noHigh courtDanish maritimeCommercial high courtDanish insolvencyKempharm denmarkSubsequently orphazymeChief executive officerChief financial officerSommer schmidtRestructuring administratorNasdaq copenhagenOrphan drug designation

Changes to the Board of Directors - Press Release

Orphazyme A/S in restructuringCompany announcement No. 27/2022 www.orphazyme.comCompany Registration No. 32266355Copenhagen, Denmark, May 23, 2022 –

Georges gemayelAndrew merciecaAnders vadsholtMartin bondeBo jesper hansenJohn sommer schmidtCarrolee barlowAnders fink vadsholtStephanie okeyNomination committeeCompany registration noHigh court theDrug administrationScience committeeRemuneration committeeAudit committee

Changes to the Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Georges gemayelAndrew merciecaAnders vadsholtMartin bondeBo jesper hansenJohn sommer schmidtCarrolee barlowAnders fink vadsholtStephanie okeyNomination committeeCompany registration noHigh court theDrug administrationScience committeeRemuneration committeeAudit committee

Changes to the Board of Directors - May 23, 2022

Changes to the Board of Directors - May 23, 2022 - read this article along with other careers information, tips and advice on BioSpace

Georges gemayelAndrew merciecaAnders vadsholtMartin bondeBo jesper hansenJohn sommer schmidtCarrolee barlowAnders fink vadsholtStephanie okeyNomination committeeCompany registration noHigh court theDrug administrationScience committeeRemuneration committeeAudit committee

Restructuring Proposal

Orphazyme A/S in restructuringCompany announcementNo. 26/2022 Inside.

John sommer schmidtAnders vadsholtHigh court theDrug administrationCompany registration noHigh courtDanish maritimeCommercial high courtKempharm denmarkRestructuring proposalChief executive officerChief financial officerSommer schmidtRestructuring administratorNasdaq copenhagenOrphan drug designation

vimarsana © 2020. All Rights Reserved.